Robert Karsunky

Director of Finance/CFO at Novartis Pharma AG

Health Technology

Consumer Services

Profile

Robert Karsunky is currently a Director at Cellestia Biotech AG and a former Chief Financial Officer at Novartis Pharma AG.
He also previously worked as the Chief Financial Officer & Senior Vice President at Alcon AG.
He obtained an undergraduate degree from Universität zu Köln.

Robert Karsunky active positions

Companies	Position	Start
Novartis Pharma AG Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland.	Director of Finance/CFO	30/06/2013
Cellestia Biotech AG Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland.	Director/Board Member	-

All active positions of Robert Karsunky

Former positions of Robert Karsunky

Companies	Position	End
ALCON INC.	Director of Finance/CFO	-

See the detail of Robert Karsunky's experience

Training of Robert Karsunky

Universität zu Köln

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Robert Karsunky's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
ALCON INC.	Health Technology

Private companies	2
Novartis Pharma AG Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland.	Health Technology
Cellestia Biotech AG Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland.	Health Technology